It could very well be, that in FFC-fed mice displaying only early signs of steatosis with beginning inflammatory alterations, clearance of LTA through TLR1 in intestinal tissue and liver was efficient enough to avoid a marked increase of LTA in the portal vein. The gene discussed is TLR1; the disease is steatosis.